SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-054758
Filing Date
2023-07-05
Accepted
2023-07-05 16:05:19
Documents
12
Period of Report
2023-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181311-8k_longeveron.htm   iXBRL 8-K 27852
  Complete submission text file 0001213900-23-054758.txt   203550

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lgvn-20230630.xsd EX-101.SCH 2965
3 XBRL LABEL FILE lgvn-20230630_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lgvn-20230630_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT ea181311-8k_longeveron_htm.xml XML 3710
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 231068765
SIC: 2834 Pharmaceutical Preparations